Suppr超能文献

吸入氯丁醇对哮喘患者气道的影响。

The airways effects of inhaled chlorbutol in asthmatic subjects.

作者信息

Windom H, Burgess C, Crane J, Beasley R

机构信息

Dept of Medicine, Wellington School of Medicine, New Zealand.

出版信息

Eur Respir J. 1990 Jun;3(6):725-7.

PMID:2199211
Abstract

Chlorbutol is an antibacterial and antifungal agent incorporated in terbutaline (Bricanyl) nebulizer solution. Ten stable atopic asthmatic subjects undertook bronchial challenge testing, according to a double-blind protocol. Patients inhaled doubling concentrations of either methacholine (0.13-4.0 mg.ml-1) or chlorbutol (0.16-5.0 mg.ml-1) for 2 min until the forced expiratory volume in one second (FEV1) had fallen by 20% from baseline. If this had not occurred following the administration of the final concentration, then this highest concentration was repeated for 4 min. The nine subjects completing the study had a geometric mean provocation concentration producing a 20% fall from baseline FEV1 (PC20) methacholine of 0.16 mg.ml-1 (range less than 0.125-0.475 mg.ml-1). After inhalation of 2.5 mg.ml-1 chlorbutol one subject experienced a fall in FEV1 greater than 20%. In the remaining eight subjects, inhalation of chlorbutol did not affect airway calibre. We conclude that chlorbutol, in the concentration present in Bricanyl nebulizer solution, has no clinically significant effect on airway calibre.

摘要

三氯叔丁醇是一种抗菌和抗真菌剂,被添加到特布他林(博利康尼)雾化液中。10名稳定期特应性哮喘患者按照双盲方案进行了支气管激发试验。患者吸入双倍浓度的乙酰甲胆碱(0.13 - 4.0 mg.ml-1)或三氯叔丁醇(0.16 - 5.0 mg.ml-1),持续2分钟,直到一秒用力呼气量(FEV1)较基线下降20%。如果在给予最终浓度后未出现这种情况,则将该最高浓度重复吸入4分钟。完成研究的9名受试者乙酰甲胆碱使FEV1从基线下降20%(PC20)的几何平均激发浓度为0.16 mg.ml-1(范围小于0.125 - 0.475 mg.ml-1)。吸入2.5 mg.ml-1三氯叔丁醇后,1名受试者的FEV1下降超过20%。在其余8名受试者中,吸入三氯叔丁醇未影响气道口径。我们得出结论,博利康尼雾化液中所含浓度的三氯叔丁醇对气道口径无临床显著影响。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验